This year. We're going Beyond.

Small Caps & Management, ft. Claude Walker

iTunes – Spotify – Castbox – YouTube 

Analysing company management with A Rich Life’s Claude Walker

This podcast features Claude Walker from A Rich Life. Claude is an independent journalist and former investment analyst who is passionate about small cap and ethical investing. 

He believes one of his key investment edges lies in identifying management teams that are either very high quality or very poor. 

In this conversation, we talk about some simple (and less than simple) strategies to identify management teams with talent and integrity, in particular small-cap companies on the ASX. 

Strategies discussed includes:

  • Management communication
  • Assessing incentives of key people 
  • What is skin in the game?!
  • Good horses versus good jockeys 
  • Management teams with technical skills
  • Using management signals confirm business fundamentals 
  • Claude says, “actions can confirm what you thought was happening in the numbers” 
  • Spotting and interpreting management accounting tricks

We also talk about PR agencies and the problem with incentives in today’s era of investment news and regulation. Be careful where you get your financial “news”. 

Companies discussed:

  • @43:00 – OneView Health (ASX: ONE) and the recent (and a little concerning) agreement with the S3 Consortium. Neither Owen nor Claude have any interest in this company (long or short). We just found this agreement very bizarre. 
  • Pro Medicus Ltd (ASX: PME)
  • MyDeal (ASX: MYD)
  • Nanosonics Ltd (ASX: NAN)
  • Commonwealth Bank (ASX: CBA) (in passing)
  • Okta Inc (NASDAQ: OKTA)
  • Corum Group (ASX: COO)
  • Urbanise.com (ASX: UBN)
  • Monash Health (ASX: MVF)

Keep up to date with Claude’s work at A Rich Life: 

Listen to Owen’s prior episode with Claude

Say g’day on Twitter: 

At the time of writing, Owen Raszkiewicz owns shares of Okta and Pro Medicus. 

Recorded Wednesday Wednesday, March 17th. 

The information on this website and in our podcasts is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.

Share this episode:

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp

Search finance answers:
Generic filters

Like our podcast?
Get Owen’s weekly newsletter.

Like our podcast? Get Owen's weekly newsletter.

Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 25,000 Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.

arrow-03

Like our podcast?
Get Owen's weekly newsletter.

Want to level-up your analytical skills and investing insights but don’t know where to start?
We can help.
Join 25,000 Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.

Join the short list

Make sure you keep an eye on your email, we will be in touch soon.